BLENDED LEARNING COURSE IN MEDICAL AFFAIRS TO IMPROVE EXPOSURE AND INTEREST IN PHARMACEUTICAL INDUSTRY CAREERS.

Objective: The study aimed to evaluate student knowledge and perceptions regarding career options and knowledge of the pharmaceutical industry based on pre-post module quizzes, reflections and team presentations in a hybrid medical affairs elective certificate course.

Methods: A qualitative research design was utilized to analyze reflections from 19 students enrolled in the Accreditation Council for Medical Affairs (ACMA) Pharmaceutical Industry Training Certificate elective at Marshall University during Spring 2023. The course utilized seven modules from the Medical Affairs Competency Certificate (MACC) offered by ACMA.

Chemical stability of naloxone products beyond their labeled expiration dates.

Objective: The purpose of this study was to evaluate the chemical stability of previously dispensed, expired naloxone products.

Setting: When properly stored, certain products maintain stable, defined as within compendia acceptability, beyond their manufacturer's expiration date. Stockpiling life-saving medications such as the opioid overdose reversing agent naloxone nasal spray (NNS) or injection (NIJ) is of utmost importance to ensure public health emergency preparedness and response.

COVID-19 and Vaccine Hesitancy: A Challenge the United States Must Overcome.

A significant portion of the U.S. population may experience vaccine hesitancy of a new COVID-19 vaccine, which poses dangers to both the individual and their community, since exposure to a contagious disease places the person at risk, and individuals are far more likely to spread the disease to others if they do not get vaccinated.

Clinical applications of neurochemical and electrophysiological measurements for closed-loop neurostimulation.

The development of closed-loop deep brain stimulation (DBS) systems represents a significant opportunity for innovation in the clinical application of neurostimulation therapies. Despite the highly dynamic nature of neurological diseases, open-loop DBS applications are incapable of modifying parameters in real time to react to fluctuations in disease states. Thus, current practice for the designation of stimulation parameters, such as duration, amplitude, and pulse frequency, is an algorithmic process.